View an archived version of our recent webinar

.

Using NGS to characterize cell lines used for production of biologics: Verifying clonality and identity

Regulatory authorities require high level of confirmation of the characteristics of a cell line including its provenience and clonality to ensure safety, reproducibility and product efficacy. Full genome characterization of your cell line provides support for its identity and clonality and ensures you and your team are on the right path.

The utilization of next-generation sequencing (NGS) to identify the presence, absence or prevalence of SNPs enables identification of possible differing strains and lineages within the cell line. Identifying the integration sequence, the precise sequence of the plasmid fragment integrated into the cell line and rearrangements or copies via deep sequencing can provide strong documentation for clonality and validation with respect to the product quality during manufacturing and as an “end-of-process control” for batch release.

Join us to learn more about the use of the latest sequencing technologies for the characterization of your cell lines.

.


 

You can view a replay of this free webinar by clicking on the button above.


 

Experts presenting during webinar

Nicole Borth, Ph.D.
Professor of Cell Biology and Cytometry
University of Natural Resources and Life Science (BOKU)
Area Leader, Austrian Center of Industrial Biotechnology (ACIB)
Vienna, Austria

 

Stéphane Cruveiller, Ph.D.
Chief Technology Information Officer
PathoQuest SAS
Paris, France

.


.

Sponsored by: